The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The “Artificial Pancreas Device System (APDS) Industry Forecast” looks at past sales and reviews total world Artificial Pancreas Device System (APDS) sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Pancreas Device System (APDS) sales for 2023 through 2029. With Artificial Pancreas Device System (APDS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Pancreas Device System (APDS) industry.
This Insight Report provides a comprehensive analysis of the global Artificial Pancreas Device System (APDS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Pancreas Device System (APDS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Pancreas Device System (APDS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Pancreas Device System (APDS) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Pancreas Device System (APDS).
The global Artificial Pancreas Device System (APDS) market size is projected to grow from US$ 70 million in 2022 to US$ 159.8 million in 2029; it is expected to grow at a CAGR of 12.6% from 2023 to 2029.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Pancreas Device System (APDS) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Pancreas Device System (APDS) Market Size 2018-2029
2.1.2 Artificial Pancreas Device System (APDS) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Artificial Pancreas Device System (APDS) Segment by Type
2.2.1 Threshold Suspended Device Systems
2.2.2 Hybrid Closed-loop APDS
2.2.3 Other Systems
2.3 Artificial Pancreas Device System (APDS) Market Size by Type
2.3.1 Artificial Pancreas Device System (APDS) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Artificial Pancreas Device System (APDS) Market Size Market Share by Type (2018-2023)
2.4 Artificial Pancreas Device System (APDS) Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Artificial Pancreas Device System (APDS) Market Size by Application
2.5.1 Artificial Pancreas Device System (APDS) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Artificial Pancreas Device System (APDS) Market Size Market Share by Application (2018-2023)
3 Artificial Pancreas Device System (APDS) Market Size by Player
3.1 Artificial Pancreas Device System (APDS) Market Size Market Share by Players
3.1.1 Global Artificial Pancreas Device System (APDS) Revenue by Players (2018-2023)
3.1.2 Global Artificial Pancreas Device System (APDS) Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Pancreas Device System (APDS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Pancreas Device System (APDS) by Regions
4.1 Artificial Pancreas Device System (APDS) Market Size by Regions (2018-2023)
4.2 Americas Artificial Pancreas Device System (APDS) Market Size Growth (2018-2023)
4.3 APAC Artificial Pancreas Device System (APDS) Market Size Growth (2018-2023)
4.4 Europe Artificial Pancreas Device System (APDS) Market Size Growth (2018-2023)
4.5 Middle East & Africa Artificial Pancreas Device System (APDS) Market Size Growth (2018-2023)
5 Americas
5.1 Americas Artificial Pancreas Device System (APDS) Market Size by Country (2018-2023)
5.2 Americas Artificial Pancreas Device System (APDS) Market Size by Type (2018-2023)
5.3 Americas Artificial Pancreas Device System (APDS) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Pancreas Device System (APDS) Market Size by Region (2018-2023)
6.2 APAC Artificial Pancreas Device System (APDS) Market Size by Type (2018-2023)
6.3 APAC Artificial Pancreas Device System (APDS) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Pancreas Device System (APDS) by Country (2018-2023)
7.2 Europe Artificial Pancreas Device System (APDS) Market Size by Type (2018-2023)
7.3 Europe Artificial Pancreas Device System (APDS) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Pancreas Device System (APDS) by Region (2018-2023)
8.2 Middle East & Africa Artificial Pancreas Device System (APDS) Market Size by Type (2018-2023)
8.3 Middle East & Africa Artificial Pancreas Device System (APDS) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Pancreas Device System (APDS) Market Forecast
10.1 Global Artificial Pancreas Device System (APDS) Forecast by Regions (2024-2029)
10.1.1 Global Artificial Pancreas Device System (APDS) Forecast by Regions (2024-2029)
10.1.2 Americas Artificial Pancreas Device System (APDS) Forecast
10.1.3 APAC Artificial Pancreas Device System (APDS) Forecast
10.1.4 Europe Artificial Pancreas Device System (APDS) Forecast
10.1.5 Middle East & Africa Artificial Pancreas Device System (APDS) Forecast
10.2 Americas Artificial Pancreas Device System (APDS) Forecast by Country (2024-2029)
10.2.1 United States Artificial Pancreas Device System (APDS) Market Forecast
10.2.2 Canada Artificial Pancreas Device System (APDS) Market Forecast
10.2.3 Mexico Artificial Pancreas Device System (APDS) Market Forecast
10.2.4 Brazil Artificial Pancreas Device System (APDS) Market Forecast
10.3 APAC Artificial Pancreas Device System (APDS) Forecast by Region (2024-2029)
10.3.1 China Artificial Pancreas Device System (APDS) Market Forecast
10.3.2 Japan Artificial Pancreas Device System (APDS) Market Forecast
10.3.3 Korea Artificial Pancreas Device System (APDS) Market Forecast
10.3.4 Southeast Asia Artificial Pancreas Device System (APDS) Market Forecast
10.3.5 India Artificial Pancreas Device System (APDS) Market Forecast
10.3.6 Australia Artificial Pancreas Device System (APDS) Market Forecast
10.4 Europe Artificial Pancreas Device System (APDS) Forecast by Country (2024-2029)
10.4.1 Germany Artificial Pancreas Device System (APDS) Market Forecast
10.4.2 France Artificial Pancreas Device System (APDS) Market Forecast
10.4.3 UK Artificial Pancreas Device System (APDS) Market Forecast
10.4.4 Italy Artificial Pancreas Device System (APDS) Market Forecast
10.4.5 Russia Artificial Pancreas Device System (APDS) Market Forecast
10.5 Middle East & Africa Artificial Pancreas Device System (APDS) Forecast by Region (2024-2029)
10.5.1 Egypt Artificial Pancreas Device System (APDS) Market Forecast
10.5.2 South Africa Artificial Pancreas Device System (APDS) Market Forecast
10.5.3 Israel Artificial Pancreas Device System (APDS) Market Forecast
10.5.4 Turkey Artificial Pancreas Device System (APDS) Market Forecast
10.5.5 GCC Countries Artificial Pancreas Device System (APDS) Market Forecast
10.6 Global Artificial Pancreas Device System (APDS) Forecast by Type (2024-2029)
10.7 Global Artificial Pancreas Device System (APDS) Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Artificial Pancreas Device System (APDS) Product Offered
11.1.3 Medtronic Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Medtronic Main Business Overview
11.1.5 Medtronic Latest Developments
11.2 Bigfoot Biomedical
11.2.1 Bigfoot Biomedical Company Information
11.2.2 Bigfoot Biomedical Artificial Pancreas Device System (APDS) Product Offered
11.2.3 Bigfoot Biomedical Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bigfoot Biomedical Main Business Overview
11.2.5 Bigfoot Biomedical Latest Developments
11.3 Beta Bionics
11.3.1 Beta Bionics Company Information
11.3.2 Beta Bionics Artificial Pancreas Device System (APDS) Product Offered
11.3.3 Beta Bionics Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Beta Bionics Main Business Overview
11.3.5 Beta Bionics Latest Developments
11.4 Admetsys
11.4.1 Admetsys Company Information
11.4.2 Admetsys Artificial Pancreas Device System (APDS) Product Offered
11.4.3 Admetsys Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Admetsys Main Business Overview
11.4.5 Admetsys Latest Developments
11.5 Insulet
11.5.1 Insulet Company Information
11.5.2 Insulet Artificial Pancreas Device System (APDS) Product Offered
11.5.3 Insulet Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Insulet Main Business Overview
11.5.5 Insulet Latest Developments
11.6 Tandem Diabetes Care
11.6.1 Tandem Diabetes Care Company Information
11.6.2 Tandem Diabetes Care Artificial Pancreas Device System (APDS) Product Offered
11.6.3 Tandem Diabetes Care Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Tandem Diabetes Care Main Business Overview
11.6.5 Tandem Diabetes Care Latest Developments
11.7 Defymed
11.7.1 Defymed Company Information
11.7.2 Defymed Artificial Pancreas Device System (APDS) Product Offered
11.7.3 Defymed Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Defymed Main Business Overview
11.7.5 Defymed Latest Developments
12 Research Findings and Conclusion
*If Applicable.